| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 30 | 2020 | 702 | 5.930 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 11 | 2022 | 75 | 3.710 |
Why?
|
| Liver | 26 | 2022 | 471 | 3.220 |
Why?
|
| Prenatal Exposure Delayed Effects | 14 | 2020 | 136 | 3.180 |
Why?
|
| Diabetes, Gestational | 13 | 2020 | 73 | 3.090 |
Why?
|
| Fatty Liver | 12 | 2014 | 77 | 2.920 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 9 | 2016 | 26 | 2.750 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 8 | 2021 | 73 | 2.300 |
Why?
|
| Pregnancy | 42 | 2022 | 1260 | 2.160 |
Why?
|
| Muscle, Skeletal | 11 | 2016 | 641 | 2.010 |
Why?
|
| Gastrointestinal Microbiome | 6 | 2022 | 138 | 1.600 |
Why?
|
| Insulin Resistance | 15 | 2019 | 176 | 1.490 |
Why?
|
| Diet, High-Fat | 11 | 2022 | 144 | 1.440 |
Why?
|
| Fatty Acids | 4 | 2017 | 221 | 1.260 |
Why?
|
| Birth Weight | 4 | 2020 | 63 | 1.250 |
Why?
|
| Insulin | 15 | 2022 | 325 | 1.170 |
Why?
|
| Lipid Metabolism | 13 | 2022 | 152 | 1.160 |
Why?
|
| Fetus | 9 | 2018 | 79 | 1.150 |
Why?
|
| Oxidative Stress | 10 | 2022 | 678 | 1.150 |
Why?
|
| Inflammation | 8 | 2018 | 668 | 1.150 |
Why?
|
| Animals | 47 | 2022 | 10715 | 1.130 |
Why?
|
| Adiposity | 6 | 2022 | 94 | 1.100 |
Why?
|
| Female | 51 | 2022 | 15690 | 1.090 |
Why?
|
| Pregnancy Complications | 5 | 2018 | 112 | 1.000 |
Why?
|
| Dietary Fats | 5 | 2017 | 59 | 0.970 |
Why?
|
| Mitochondria, Liver | 2 | 2018 | 12 | 0.960 |
Why?
|
| Diet | 7 | 2020 | 241 | 0.880 |
Why?
|
| Mice | 23 | 2022 | 4815 | 0.850 |
Why?
|
| Gene Expression Regulation | 9 | 2021 | 635 | 0.850 |
Why?
|
| Sirtuin 3 | 3 | 2013 | 18 | 0.820 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2017 | 43 | 0.820 |
Why?
|
| Energy Metabolism | 7 | 2019 | 216 | 0.790 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2022 | 40 | 0.770 |
Why?
|
| Fetal Development | 4 | 2018 | 26 | 0.760 |
Why?
|
| Breast Feeding | 2 | 2020 | 99 | 0.740 |
Why?
|
| Mitochondria | 6 | 2020 | 410 | 0.700 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 3 | 2012 | 6 | 0.690 |
Why?
|
| Maternal Exposure | 2 | 2021 | 29 | 0.670 |
Why?
|
| Infant Formula | 1 | 2020 | 18 | 0.660 |
Why?
|
| Pediatric Obesity | 2 | 2022 | 79 | 0.660 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2020 | 22 | 0.660 |
Why?
|
| Muscle Proteins | 3 | 2014 | 56 | 0.650 |
Why?
|
| Endoplasmic Reticulum | 3 | 2010 | 80 | 0.650 |
Why?
|
| Fatty Acid Desaturases | 1 | 2020 | 16 | 0.640 |
Why?
|
| Transgenes | 1 | 2020 | 63 | 0.630 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2020 | 58 | 0.620 |
Why?
|
| Mothers | 3 | 2018 | 126 | 0.620 |
Why?
|
| Osteoarthritis | 1 | 2020 | 39 | 0.620 |
Why?
|
| Macaca | 9 | 2018 | 20 | 0.610 |
Why?
|
| Humans | 34 | 2022 | 28998 | 0.600 |
Why?
|
| Macrophages | 4 | 2016 | 306 | 0.590 |
Why?
|
| Infant, Newborn | 7 | 2020 | 924 | 0.590 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 3 | 2010 | 5 | 0.590 |
Why?
|
| Cholesterol | 2 | 2021 | 204 | 0.590 |
Why?
|
| Gluconeogenesis | 6 | 2018 | 16 | 0.580 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 2 | 2016 | 28 | 0.580 |
Why?
|
| Metabolomics | 3 | 2017 | 87 | 0.580 |
Why?
|
| PQQ Cofactor | 2 | 2022 | 7 | 0.560 |
Why?
|
| Gene Expression | 3 | 2017 | 417 | 0.550 |
Why?
|
| Male | 23 | 2022 | 13983 | 0.540 |
Why?
|
| Hypoxia | 1 | 2018 | 90 | 0.540 |
Why?
|
| Hyperglycemia | 3 | 2022 | 78 | 0.540 |
Why?
|
| Fatty Acids, Omega-6 | 2 | 2017 | 22 | 0.530 |
Why?
|
| Adenylate Kinase | 3 | 2014 | 8 | 0.520 |
Why?
|
| Fetal Growth Retardation | 4 | 2019 | 32 | 0.520 |
Why?
|
| Hyperlipidemias | 2 | 2016 | 38 | 0.520 |
Why?
|
| DNA Methylation | 2 | 2017 | 153 | 0.510 |
Why?
|
| Receptor, Insulin | 8 | 2022 | 93 | 0.500 |
Why?
|
| RNA, Messenger | 8 | 2017 | 668 | 0.500 |
Why?
|
| Mitochondrial Proteins | 2 | 2014 | 80 | 0.500 |
Why?
|
| Signal Transduction | 13 | 2022 | 1470 | 0.480 |
Why?
|
| Macrophage Activation | 2 | 2014 | 32 | 0.480 |
Why?
|
| Bone Marrow | 1 | 2016 | 83 | 0.460 |
Why?
|
| Blood Glucose | 7 | 2019 | 310 | 0.450 |
Why?
|
| Diet, Western | 3 | 2021 | 45 | 0.450 |
Why?
|
| Atherosclerosis | 1 | 2016 | 97 | 0.450 |
Why?
|
| Infant | 5 | 2022 | 1049 | 0.450 |
Why?
|
| Triglycerides | 7 | 2018 | 123 | 0.450 |
Why?
|
| Antioxidants | 1 | 2016 | 224 | 0.440 |
Why?
|
| Hepacivirus | 2 | 2012 | 49 | 0.440 |
Why?
|
| Amino Acids | 1 | 2015 | 85 | 0.430 |
Why?
|
| Fenofibrate | 2 | 2016 | 8 | 0.430 |
Why?
|
| Adult | 15 | 2022 | 8048 | 0.420 |
Why?
|
| Calcium Signaling | 1 | 2014 | 72 | 0.420 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2010 | 133 | 0.420 |
Why?
|
| Electron Transport Complex II | 1 | 2013 | 5 | 0.410 |
Why?
|
| Superoxide Dismutase | 1 | 2013 | 71 | 0.390 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2012 | 5 | 0.390 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2012 | 7 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 7 | 2022 | 1661 | 0.390 |
Why?
|
| Anticholesteremic Agents | 1 | 2012 | 13 | 0.390 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2012 | 12 | 0.380 |
Why?
|
| Adipose Tissue, Brown | 1 | 2012 | 22 | 0.380 |
Why?
|
| Genome, Viral | 1 | 2012 | 34 | 0.380 |
Why?
|
| Child | 7 | 2022 | 2327 | 0.370 |
Why?
|
| Diabetes Mellitus | 2 | 2007 | 215 | 0.370 |
Why?
|
| Risk Factors | 7 | 2022 | 2134 | 0.370 |
Why?
|
| Sulfonamides | 1 | 2012 | 73 | 0.370 |
Why?
|
| Microbiota | 3 | 2022 | 98 | 0.360 |
Why?
|
| Body Mass Index | 5 | 2022 | 415 | 0.360 |
Why?
|
| Liver Neoplasms | 2 | 2010 | 167 | 0.350 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2022 | 344 | 0.350 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2006 | 135 | 0.340 |
Why?
|
| Epigenesis, Genetic | 3 | 2018 | 148 | 0.330 |
Why?
|
| Up-Regulation | 2 | 2010 | 247 | 0.320 |
Why?
|
| Phosphoproteins | 7 | 2006 | 120 | 0.320 |
Why?
|
| Adipose Tissue | 7 | 2018 | 197 | 0.320 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2007 | 251 | 0.310 |
Why?
|
| Glucose Tolerance Test | 6 | 2014 | 60 | 0.310 |
Why?
|
| Receptors, Adiponectin | 1 | 2009 | 5 | 0.310 |
Why?
|
| Phenylbutyrates | 1 | 2009 | 3 | 0.310 |
Why?
|
| Bacteria | 3 | 2020 | 286 | 0.280 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 514 | 0.280 |
Why?
|
| PPAR gamma | 4 | 2017 | 29 | 0.280 |
Why?
|
| Dietary Supplements | 4 | 2022 | 273 | 0.280 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2015 | 22 | 0.260 |
Why?
|
| Lipoprotein Lipase | 3 | 2018 | 10 | 0.260 |
Why?
|
| Oxidation-Reduction | 3 | 2017 | 381 | 0.250 |
Why?
|
| Biomarkers | 5 | 2022 | 782 | 0.250 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2012 | 25 | 0.240 |
Why?
|
| Enzyme Activation | 3 | 2012 | 267 | 0.240 |
Why?
|
| Cytokines | 5 | 2016 | 452 | 0.240 |
Why?
|
| Cell Line, Tumor | 4 | 2012 | 1351 | 0.230 |
Why?
|
| Placenta | 2 | 2018 | 78 | 0.230 |
Why?
|
| Gene Expression Profiling | 5 | 2021 | 466 | 0.230 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2016 | 16 | 0.220 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2018 | 8 | 0.220 |
Why?
|
| Glucose Clamp Technique | 3 | 2019 | 12 | 0.210 |
Why?
|
| Glucose | 4 | 2012 | 209 | 0.210 |
Why?
|
| Primates | 3 | 2021 | 22 | 0.210 |
Why?
|
| Phosphorylation | 5 | 2014 | 585 | 0.210 |
Why?
|
| Apoptosis | 3 | 2018 | 780 | 0.190 |
Why?
|
| Insulin Receptor Substrate Proteins | 7 | 2006 | 23 | 0.190 |
Why?
|
| Transcription Factors | 2 | 2007 | 523 | 0.190 |
Why?
|
| Insulins | 1 | 2022 | 6 | 0.190 |
Why?
|
| Bile Acids and Salts | 2 | 2021 | 25 | 0.190 |
Why?
|
| NEDD8 Protein | 1 | 2022 | 7 | 0.180 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 24 | 0.180 |
Why?
|
| Cullin Proteins | 1 | 2022 | 12 | 0.180 |
Why?
|
| Dysbiosis | 2 | 2018 | 15 | 0.180 |
Why?
|
| Cyclopentanes | 1 | 2022 | 17 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2002 | 51 | 0.180 |
Why?
|
| Blotting, Western | 5 | 2019 | 515 | 0.180 |
Why?
|
| Thiazepines | 1 | 2021 | 4 | 0.170 |
Why?
|
| Methylamines | 1 | 2021 | 6 | 0.170 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 26 | 0.170 |
Why?
|
| Response Elements | 2 | 2011 | 22 | 0.170 |
Why?
|
| Neoplasm Proteins | 1 | 2002 | 123 | 0.170 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 78 | 0.170 |
Why?
|
| Feces | 2 | 2018 | 117 | 0.170 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2018 | 12 | 0.170 |
Why?
|
| Pyrimidines | 1 | 2022 | 128 | 0.170 |
Why?
|
| Adolescent | 4 | 2022 | 3223 | 0.170 |
Why?
|
| Lipids | 4 | 2018 | 220 | 0.170 |
Why?
|
| Mammary Glands, Human | 1 | 2020 | 19 | 0.170 |
Why?
|
| Rats | 4 | 2012 | 1592 | 0.170 |
Why?
|
| Immune System | 1 | 2020 | 29 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2022 | 125 | 0.160 |
Why?
|
| Glucose-6-Phosphatase | 3 | 2012 | 5 | 0.160 |
Why?
|
| Thapsigargin | 2 | 2010 | 8 | 0.160 |
Why?
|
| Postpartum Period | 3 | 2020 | 79 | 0.160 |
Why?
|
| Mice, Knockout | 4 | 2012 | 876 | 0.160 |
Why?
|
| Phenotype | 2 | 2013 | 687 | 0.160 |
Why?
|
| Lactation | 1 | 2020 | 77 | 0.160 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2017 | 10 | 0.160 |
Why?
|
| Caenorhabditis elegans | 1 | 2020 | 62 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 3 | 2017 | 344 | 0.160 |
Why?
|
| Computational Biology | 1 | 2020 | 156 | 0.150 |
Why?
|
| Milk, Human | 1 | 2020 | 101 | 0.150 |
Why?
|
| Germ-Free Life | 1 | 2018 | 3 | 0.150 |
Why?
|
| Fatty Acids, Volatile | 1 | 2018 | 15 | 0.150 |
Why?
|
| Parents | 1 | 2020 | 142 | 0.150 |
Why?
|
| Mice, Mutant Strains | 2 | 2012 | 58 | 0.140 |
Why?
|
| Citric Acid Cycle | 1 | 2018 | 16 | 0.140 |
Why?
|
| Disease Progression | 1 | 2020 | 479 | 0.140 |
Why?
|
| Preconception Care | 1 | 2018 | 18 | 0.140 |
Why?
|
| Synbiotics | 1 | 2018 | 1 | 0.140 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2009 | 33 | 0.140 |
Why?
|
| Risk Assessment | 1 | 2020 | 631 | 0.140 |
Why?
|
| PPAR alpha | 3 | 2022 | 34 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 74 | 0.140 |
Why?
|
| Bone Marrow Cells | 2 | 2016 | 81 | 0.140 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 381 | 0.140 |
Why?
|
| Micronutrients | 1 | 2018 | 49 | 0.140 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2017 | 4 | 0.140 |
Why?
|
| Young Adult | 4 | 2018 | 2842 | 0.130 |
Why?
|
| Muscle Development | 1 | 2017 | 9 | 0.130 |
Why?
|
| Adipogenesis | 1 | 2017 | 27 | 0.130 |
Why?
|
| Umbilical Cord | 1 | 2017 | 35 | 0.130 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 198 | 0.130 |
Why?
|
| Gestational Age | 4 | 2019 | 147 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2017 | 427 | 0.130 |
Why?
|
| Caloric Restriction | 2 | 2011 | 74 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 40 | 0.130 |
Why?
|
| Ceramides | 1 | 2016 | 33 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 68 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2020 | 303 | 0.130 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2016 | 51 | 0.120 |
Why?
|
| Hypoglycemic Agents | 3 | 2008 | 110 | 0.120 |
Why?
|
| Foam Cells | 1 | 2016 | 8 | 0.120 |
Why?
|
| Carrier Proteins | 2 | 2012 | 256 | 0.120 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2016 | 5 | 0.120 |
Why?
|
| RAW 264.7 Cells | 1 | 2016 | 21 | 0.120 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 31 | 0.120 |
Why?
|
| Space Flight | 1 | 2016 | 17 | 0.120 |
Why?
|
| Hematopoiesis | 1 | 2016 | 25 | 0.120 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 1511 | 0.120 |
Why?
|
| Gene Silencing | 1 | 2016 | 65 | 0.120 |
Why?
|
| Endocrinology | 1 | 2015 | 3 | 0.120 |
Why?
|
| Haplorhini | 1 | 2015 | 15 | 0.120 |
Why?
|
| Diet, Fat-Restricted | 1 | 2015 | 5 | 0.120 |
Why?
|
| Diet, Diabetic | 1 | 2015 | 4 | 0.120 |
Why?
|
| Body Weight | 4 | 2016 | 253 | 0.120 |
Why?
|
| Awards and Prizes | 1 | 2015 | 9 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2016 | 198 | 0.110 |
Why?
|
| Glucose Transporter Type 4 | 3 | 2006 | 63 | 0.110 |
Why?
|
| Carnitine | 1 | 2015 | 6 | 0.110 |
Why?
|
| Proteomics | 2 | 2014 | 197 | 0.110 |
Why?
|
| Postprandial Period | 1 | 2015 | 51 | 0.110 |
Why?
|
| Electron Transport | 1 | 2014 | 31 | 0.110 |
Why?
|
| Animal Feed | 1 | 2014 | 21 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 679 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2017 | 485 | 0.100 |
Why?
|
| Sheep, Domestic | 2 | 2019 | 6 | 0.100 |
Why?
|
| Glutathione | 1 | 2013 | 76 | 0.100 |
Why?
|
| Stilbenes | 1 | 2014 | 91 | 0.100 |
Why?
|
| Leptin | 3 | 2018 | 67 | 0.100 |
Why?
|
| Liver X Receptors | 1 | 2012 | 22 | 0.100 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 3 | 0.100 |
Why?
|
| Cell Line | 2 | 2022 | 701 | 0.100 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 58 | 0.100 |
Why?
|
| Secretory Vesicles | 1 | 2012 | 12 | 0.100 |
Why?
|
| Lipogenesis | 1 | 2012 | 29 | 0.100 |
Why?
|
| Enzyme Induction | 1 | 2012 | 28 | 0.100 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2012 | 12 | 0.100 |
Why?
|
| Antigens, Differentiation | 1 | 2012 | 21 | 0.100 |
Why?
|
| Intestines | 1 | 2013 | 118 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 35 | 0.090 |
Why?
|
| 3T3-L1 Cells | 1 | 2012 | 30 | 0.090 |
Why?
|
| Transcription Factor RelA | 1 | 2012 | 22 | 0.090 |
Why?
|
| Inflammasomes | 1 | 2012 | 20 | 0.090 |
Why?
|
| Luciferases | 1 | 2012 | 54 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2012 | 41 | 0.090 |
Why?
|
| Genes, Reporter | 1 | 2012 | 87 | 0.090 |
Why?
|
| Sympathetic Nervous System | 1 | 2012 | 68 | 0.090 |
Why?
|
| Virus Replication | 1 | 2012 | 66 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2012 | 120 | 0.090 |
Why?
|
| Time Factors | 2 | 2007 | 1619 | 0.090 |
Why?
|
| Histones | 1 | 2012 | 96 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 180 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2012 | 74 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2019 | 329 | 0.090 |
Why?
|
| Sheep | 2 | 2009 | 100 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 94 | 0.080 |
Why?
|
| Mesoderm | 1 | 2010 | 16 | 0.080 |
Why?
|
| Adipocytes, White | 1 | 2010 | 10 | 0.080 |
Why?
|
| Hepatocytes | 1 | 2011 | 88 | 0.080 |
Why?
|
| Myeloid Cells | 1 | 2010 | 27 | 0.080 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2017 | 6 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2010 | 126 | 0.080 |
Why?
|
| NAD | 1 | 2011 | 104 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2017 | 183 | 0.080 |
Why?
|
| Metagenomics | 2 | 2022 | 57 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2010 | 96 | 0.080 |
Why?
|
| Tunicamycin | 1 | 2009 | 3 | 0.080 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2009 | 4 | 0.080 |
Why?
|
| Hypolipidemic Agents | 1 | 2009 | 20 | 0.080 |
Why?
|
| Placental Insufficiency | 1 | 2009 | 2 | 0.080 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2009 | 6 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 166 | 0.070 |
Why?
|
| Protein Binding | 1 | 2010 | 667 | 0.070 |
Why?
|
| Fasting | 2 | 2015 | 91 | 0.070 |
Why?
|
| Uterus | 2 | 2021 | 31 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 843 | 0.070 |
Why?
|
| Adiponectin | 2 | 2018 | 29 | 0.070 |
Why?
|
| Acute-Phase Reaction | 1 | 2007 | 4 | 0.070 |
Why?
|
| Choline Deficiency | 1 | 2007 | 5 | 0.070 |
Why?
|
| Transcription Factor CHOP | 1 | 2007 | 7 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 472 | 0.070 |
Why?
|
| Lipase | 1 | 2007 | 10 | 0.070 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2019 | 328 | 0.070 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2007 | 20 | 0.070 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2007 | 5 | 0.070 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2007 | 6 | 0.070 |
Why?
|
| eIF-2 Kinase | 1 | 2007 | 29 | 0.070 |
Why?
|
| Palmitates | 1 | 2007 | 9 | 0.070 |
Why?
|
| Methionine | 1 | 2007 | 38 | 0.070 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2007 | 17 | 0.070 |
Why?
|
| Metformin | 1 | 2007 | 36 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2022 | 1283 | 0.060 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2006 | 16 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2007 | 191 | 0.060 |
Why?
|
| Hyperinsulinism | 2 | 2005 | 17 | 0.060 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2003 | 23 | 0.060 |
Why?
|
| Acetates | 1 | 2005 | 45 | 0.060 |
Why?
|
| Myocardium | 1 | 2006 | 197 | 0.060 |
Why?
|
| Models, Biological | 2 | 2010 | 469 | 0.050 |
Why?
|
| Metabolic Syndrome | 1 | 2005 | 80 | 0.050 |
Why?
|
| Indoles | 1 | 2005 | 111 | 0.050 |
Why?
|
| Pregnancy Proteins | 1 | 2003 | 9 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2003 | 268 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2006 | 285 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 612 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2021 | 2427 | 0.050 |
Why?
|
| Age Factors | 2 | 2019 | 740 | 0.050 |
Why?
|
| Glucose Intolerance | 1 | 2003 | 24 | 0.050 |
Why?
|
| Aging | 1 | 2011 | 1019 | 0.050 |
Why?
|
| Body Composition | 3 | 2012 | 267 | 0.050 |
Why?
|
| Seroconversion | 1 | 2022 | 4 | 0.050 |
Why?
|
| Weight Gain | 1 | 2003 | 76 | 0.050 |
Why?
|
| Endotoxins | 1 | 2022 | 30 | 0.050 |
Why?
|
| Fatty Acid-Binding Protein 7 | 1 | 2002 | 1 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 46 | 0.050 |
Why?
|
| Ubiquitins | 1 | 2022 | 7 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2002 | 5 | 0.050 |
Why?
|
| Metagenome | 1 | 2022 | 52 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2022 | 33 | 0.050 |
Why?
|
| Acetylation | 2 | 2012 | 41 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2012 | 129 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 72 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 157 | 0.040 |
Why?
|
| Dependovirus | 1 | 2021 | 17 | 0.040 |
Why?
|
| Fructose | 1 | 2021 | 22 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2016 | 1022 | 0.040 |
Why?
|
| Longevity | 1 | 2022 | 141 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2021 | 118 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 272 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 303 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2021 | 124 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 56 | 0.040 |
Why?
|
| Glycogen | 2 | 2012 | 23 | 0.040 |
Why?
|
| Stem Cells | 1 | 2020 | 123 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2020 | 292 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 1032 | 0.040 |
Why?
|
| Treponema | 1 | 2019 | 7 | 0.040 |
Why?
|
| Weaning | 1 | 2019 | 18 | 0.040 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 15 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 483 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2019 | 73 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 413 | 0.040 |
Why?
|
| Guatemala | 1 | 2018 | 30 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2020 | 266 | 0.040 |
Why?
|
| Psyllium | 1 | 2018 | 2 | 0.040 |
Why?
|
| Faecalibacterium | 1 | 2018 | 3 | 0.040 |
Why?
|
| Lactobacillus | 1 | 2018 | 14 | 0.030 |
Why?
|
| Firmicutes | 1 | 2018 | 16 | 0.030 |
Why?
|
| Enterococcus | 1 | 2018 | 19 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 50 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2018 | 202 | 0.030 |
Why?
|
| Perilipin-1 | 1 | 2017 | 3 | 0.030 |
Why?
|
| Probiotics | 1 | 2018 | 19 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2018 | 80 | 0.030 |
Why?
|
| Cell Size | 1 | 2017 | 26 | 0.030 |
Why?
|
| Species Specificity | 1 | 2018 | 196 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 430 | 0.030 |
Why?
|
| Energy Intake | 1 | 2017 | 69 | 0.030 |
Why?
|
| Transcriptome | 1 | 2019 | 232 | 0.030 |
Why?
|
| Adipocytes | 1 | 2017 | 60 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2016 | 18 | 0.030 |
Why?
|
| Exons | 1 | 2016 | 43 | 0.030 |
Why?
|
| Prediabetic State | 1 | 2016 | 10 | 0.030 |
Why?
|
| Genome | 1 | 2016 | 57 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 115 | 0.030 |
Why?
|
| Hepatic Stellate Cells | 1 | 2016 | 23 | 0.030 |
Why?
|
| Lipid Droplets | 1 | 2016 | 9 | 0.030 |
Why?
|
| Systems Biology | 1 | 2016 | 22 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 739 | 0.030 |
Why?
|
| Glycemic Index | 1 | 2015 | 5 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 461 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2016 | 246 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 1004 | 0.030 |
Why?
|
| Overweight | 1 | 2015 | 114 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2017 | 825 | 0.030 |
Why?
|
| Placental Circulation | 1 | 2014 | 2 | 0.030 |
Why?
|
| Contraindications | 1 | 2014 | 13 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 555 | 0.030 |
Why?
|
| Pancreas | 1 | 2014 | 63 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 464 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2014 | 164 | 0.020 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2012 | 1 | 0.020 |
Why?
|
| Sympathetic Fibers, Postganglionic | 1 | 2012 | 1 | 0.020 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2012 | 4 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2012 | 7 | 0.020 |
Why?
|
| Neuropeptide Y | 1 | 2012 | 3 | 0.020 |
Why?
|
| Hepatitis | 1 | 2012 | 7 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2012 | 10 | 0.020 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2012 | 14 | 0.020 |
Why?
|
| COS Cells | 1 | 2012 | 49 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2012 | 80 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 26 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 151 | 0.020 |
Why?
|
| Lysine | 1 | 2012 | 78 | 0.020 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2011 | 19 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 31 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 199 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2011 | 3 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 169 | 0.020 |
Why?
|
| Cell Respiration | 1 | 2011 | 9 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2011 | 27 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2011 | 40 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 152 | 0.020 |
Why?
|
| Adipocytes, Brown | 1 | 2010 | 2 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2010 | 10 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 53 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 788 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 194 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 470 | 0.020 |
Why?
|
| Mutation | 1 | 2012 | 871 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2008 | 101 | 0.020 |
Why?
|
| Liver Glycogen | 1 | 2007 | 1 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2007 | 8 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2007 | 34 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 208 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 5608 | 0.020 |
Why?
|
| Fever | 1 | 2006 | 31 | 0.020 |
Why?
|
| Organ Size | 1 | 2006 | 88 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2005 | 13 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 157 | 0.010 |
Why?
|
| Eating | 1 | 2005 | 71 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 7428 | 0.010 |
Why?
|
| Placenta Growth Factor | 1 | 2003 | 6 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 358 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 284 | 0.010 |
Why?
|